D-0928-2017 Class III Terminated
FDA drug recall D-0928-2017 was initiated by Mckesson Packaging Services on May 30, 2017 and is designated Class III. Reason for recall: Failed Moisture Limits: Product tested out-of-specification for moisture content. The recall status is terminated (terminated Feb 6, 2020). Affected quantity: 942 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 5, 2017
- Initiation Date
- May 30, 2017
- Termination Date
- Feb 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 942 cartons
Product description
BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10
Reason for recall
Failed Moisture Limits: Product tested out-of-specification for moisture content.
Distribution pattern
Nationwide in the US
Code information
Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0928-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026